The Novo Nordisk Haemophilia Foundation is striving for access to care

The Novo Nordisk Haemophilia Foundation (NNHF) was established in 2005 as a grant-making non-profit organisation in Zurich, Switzerland. Its purpose is to address the significant need for improving care for people with haemophilia and allied bleeding disorders.

An estimated 75% of the people with haemophilia and allied bleeding disorders reside in the developing world, where many go undiagnosed and are inadequately treated. We at the foundation want to change this and envision that one day every person with such a condition will have equal access to care.

Our approach is to partner with local and international community members to create life-changing impact through NNHF funded development programmes.

Local leadership

Engaging with local communities

Our approach

How is NNHF structured and governed?

As a grant-making foundation, NNHF adheres to high foundation governance standards. We are governed by the Foundation Council and operationally managed by the NNHF Team

Our Governance

Our Origins

Our Team

Click the links above to find out who's on our Council and Management Team.

Our governance

NNHF Activity Report 2015

Download the report


Latest News

December 2016
Peru 2: Engaging social workers to support access to care
Read the final report of the Peru 2 project 

December 2016
International collaboration to improve MSK care in Thailand
Read more 

November 2016
2016 NNHF Project of the Year: Pakistan 5
Read more 

More NNHF news